A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.

MLA

Wright, Karen D., et al. “A POETIC Phase II Study of Continuous Oral Everolimus in Recurrent, Radiographically Progressive Pediatric Low-Grade Glioma.” Pediatric Blood & Cancer, vol. 68, no. 2, Feb. 2021, p. e28787. EBSCOhost, https://doi.org/10.1002/pbc.28787.

APA

Wright, K. D., Yao, X., London, W. B., Kao, P.-C., Gore, L., Hunger, S., Geyer, R., Cohen, K. J., Allen, J. C., Katzenstein, H. M., Smith, A., Boklan, J., Nazemi, K., Trippett, T., Karajannis, M., Herzog, C., Destefano, J., Direnzo, J., Pietrantonio, J., … Kieran, M. W. (2021). A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatric Blood & Cancer, 68(2), e28787. https://doi.org/10.1002/pbc.28787

Chicago

Wright, Karen D, Xiaopan Yao, Wendy B London, Pei-Chi Kao, Lia Gore, Stephen Hunger, Russ Geyer, et al. 2021. “A POETIC Phase II Study of Continuous Oral Everolimus in Recurrent, Radiographically Progressive Pediatric Low-Grade Glioma.” Pediatric Blood & Cancer 68 (2): e28787. doi:10.1002/pbc.28787.